Scott R. Gerst

1.9k total citations
47 papers, 1.4k citations indexed

About

Scott R. Gerst is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Scott R. Gerst has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Scott R. Gerst's work include Renal cell carcinoma treatment (14 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (7 papers). Scott R. Gerst is often cited by papers focused on Renal cell carcinoma treatment (14 papers), Bladder and Urothelial Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (7 papers). Scott R. Gerst collaborates with scholars based in United States, Ireland and Canada. Scott R. Gerst's co-authors include Dean F. Bajorin, Matthew I. Milowsky, A. Trout, Ashley Marie Regazzi, Jingbo Zhang, Richard Kinh Gian, Mithat Gönen, David Gallagher, Jamie C. Riches and Nicole Ishill and has published in prestigious journals such as Journal of Clinical Oncology, Radiology and Clinical Cancer Research.

In The Last Decade

Scott R. Gerst

46 papers receiving 1.3k citations

Peers

Scott R. Gerst
Barbara Bachtiary Switzerland
Melissa P. Murray United States
Taek‐Keun Nam South Korea
Carol Nieroda United States
F.J.W. ten Kate Netherlands
H Lambert United Kingdom
Rony Avritscher United States
Scott R. Gerst
Citations per year, relative to Scott R. Gerst Scott R. Gerst (= 1×) peers D. Pectasides

Countries citing papers authored by Scott R. Gerst

Since Specialization
Citations

This map shows the geographic impact of Scott R. Gerst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. Gerst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. Gerst more than expected).

Fields of papers citing papers by Scott R. Gerst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. Gerst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. Gerst. The network helps show where Scott R. Gerst may publish in the future.

Co-authorship network of co-authors of Scott R. Gerst

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. Gerst. A scholar is included among the top collaborators of Scott R. Gerst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. Gerst. Scott R. Gerst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McIntyre, Caitlin A., Jeffrey Girshman, Debra A. Goldman, et al.. (2022). Differentiation of mucinous cysts and simple cysts of the liver using preoperative imaging. Abdominal Radiology. 47(4). 1333–1340. 2 indexed citations
2.
McIntyre, Caitlin A., Scott R. Gerst, Jessica Flynn, et al.. (2020). Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery. Abdominal Radiology. 46(4). 1607–1617. 5 indexed citations
3.
Horvat, Natally, João V. Horvat, Yiming Gao, et al.. (2018). Rapid switching kVp dual energy CT: Value of reconstructed dual energy CT images and organ dose assessment in multiphasic liver CT exams. European Journal of Radiology. 102. 102–108. 21 indexed citations
4.
Horvat, Natally, Ines Nikolovski, Niamh M. Long, et al.. (2017). Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014. Abdominal Radiology. 43(1). 169–178. 45 indexed citations
5.
Zheng, Junting, Jayasree Chakraborty, Peter J. Allen, et al.. (2017). Preoperative prediction of microvascular invasion in hepatocellular carcinoma using quantitative image analysis. HPB. 19. S48–S48. 10 indexed citations
6.
Zheng, Jian, Jayasree Chakraborty, William C. Chapman, et al.. (2017). Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis. Journal of the American College of Surgeons. 225(6). 778–788e1. 68 indexed citations
7.
Abida, Wassim, Matthew I. Milowsky, Irina Ostrovnaya, et al.. (2016). Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma. Bladder Cancer. 2(1). 111–117. 7 indexed citations
9.
Doussot, Alexandre, Jill S. Gluskin, Bas Groot Koerkamp, et al.. (2015). The accuracy of pre-operative imaging in the management of hepatic cysts. HPB. 17(10). 889–895. 15 indexed citations
10.
Andikyan, Vaagn, Fady Khoury‐Collado, Scott R. Gerst, et al.. (2012). Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: Review of surgical technique, complications, and outcome. Gynecologic Oncology. 126(3). 346–350. 14 indexed citations
11.
Andikyan, Vaagn, Fady Khoury‐Collado, Yukio Sonoda, et al.. (2012). Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: An update on out of the box surgery. Gynecologic Oncology. 125(2). 404–408. 27 indexed citations
12.
Konner, Jason, Scott R. Gerst, Alexia Iasonos, et al.. (2011). Phase II Study of Intraperitoneal Paclitaxel Plus Cisplatin and Intravenous Paclitaxel Plus Bevacizumab As Adjuvant Treatment of Optimal Stage II/III Epithelial Ovarian Cancer. Journal of Clinical Oncology. 29(35). 4662–4668. 44 indexed citations
13.
Gallagher, David, Hikmat Al‐Ahmadie, Irina Ostrovnaya, et al.. (2011). Sunitinib in Urothelial Cancer: Clinical, Pharmacokinetic, and Immunohistochemical Study of Predictors of Response. European Urology. 60(2). 344–349. 16 indexed citations
14.
Weinreb, Jeffrey C., Jeffrey D. Blume, Fergus V. Coakley, et al.. (2009). Prostate Cancer: Sextant Localization at MR Imaging and MR Spectroscopic Imaging before Prostatectomy—Results of ACRIN Prospective Multi-institutional Clinicopathologic Study. Radiology. 251(1). 122–133. 163 indexed citations
15.
Bochner, Bernard H., Scott R. Gerst, Kaled M. Alektiar, et al.. (2008). Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. International Journal of Gynecological Cancer. 18(5). 1139–1144. 27 indexed citations
16.
Konner, Jason, Russell J. Schilder, Scott R. Gerst, et al.. (2008). A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer. Gynecologic Oncology. 110(2). 140–145. 62 indexed citations
17.
Zhang, Jingbo, Scott R. Gerst, Robert A. Lefkowitz, & Ariadne M. Bach. (2007). Imaging of Bladder Cancer. Radiologic Clinics of North America. 45(1). 183–205. 59 indexed citations
18.
Bell‐McGuinn, Katherine M., Jason Konner, Neeta Pandit‐Taskar, et al.. (2007). A phase I study of MORAb-003, a fully humanized monoclonal antibody against folate receptor alpha, in advanced epithelial ovarian cancer. Journal of Clinical Oncology. 25(18_suppl). 5553–5553. 1 indexed citations
19.
Sovak, Mika A., Jakob Dupont, Martee L. Hensley, et al.. (2006). Paclitaxel and carboplatin in the treatment of advanced or recurrent endometrial cancer: a large retrospective study. International Journal of Gynecological Cancer. 17(1). 197–203. 43 indexed citations
20.
Aghajanian, Carol, Paul Sabbatini, Scott R. Gerst, et al.. (2005). A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced stage ovarian, primary peritoneal, and fallopian tube cancer. Journal of Clinical Oncology. 23(16_suppl). 5047–5047. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026